search

Active clinical trials for "Hearing Loss, Sensorineural"

Results 91-100 of 270

Hearing Loss in Older Adults Study

Hearing LossSensorineural2 more

This is a prospective, 1:1 randomized controlled trial of immediate versus delayed cochlear implantation (CI) on hearing handicap, communicative function, loneliness, mental wellbeing, and cognitive functioning. Participants are randomized 1:1 to an immediate cochlear implant intervention group versus a hearing aid control intervention.

Terminated16 enrollment criteria

Congenital Cytomegalovirus: Efficacy of Antiviral Treatment in a Randomized Controlled Trial

Congenital Cytomegalovirus InfectionSensorineural Hearing Loss

The objective of the trial is to investigate whether early treatment with oral valganciclovir of infants with both congenital cytomegalovirus infection and sensorineural hearing loss can prevent progression of hearing loss.

Terminated9 enrollment criteria

The EarLens Contact Hearing Device (CHD) Spectrum Study

Hearing LossSensorineural

The EarLens System is an assistive hearing device that is intended to provide amplification for the treatment of patients with sensorineural hearing impairment. The purpose of the proposed study (Extended Investigation under the Continued Access Policy) is to continue to allow access to the investigational medical device with the collection of device utility and clinic process-flow data while the marketing application is under review at the FDA.

Completed19 enrollment criteria

Esteem New Subject Enrollment Post Approval Study

Sensorineural Hearing Loss

The New Enrollment Post-Approval Study is designed to evaluate the safety and efficacy of the Esteem Totally Implantable Hearing System in subjects suffering from moderate to severe hearing loss.

Completed26 enrollment criteria

OTO-413 in Subjects With Speech-in-Noise Hearing Impairment

Sensorineural Hearing Loss

The purpose of this study is to evaluate the safety, tolerability, and exploratory efficacy of OTO-413 administered as an intratympanic injection for the treatment of speech-in-noise hearing impairment.

Completed8 enrollment criteria

FX-322 in Sensorineural Hearing Loss

Sensorineural Hearing Loss

This is a phase 1/2 study of FX-322 at two dose levels compared to placebo in male and female adults otherwise healthy with stable sensorineural hearing loss.

Completed15 enrollment criteria

Quality Control of CE-Certified Phonak Hearing Aids - 2019_19

Hearing LossSensorineural Hearing Loss

Phonak Hearing Systems pass through different development and study stages. At an early stage, feasibility studies are conducted to investigate new algorithms, features and functions in an isolated manner. If the benefit is proven, their performance is then investigated regarding interdependency between all available algorithms, features and functions running in parallel in a hearing aid (pivotal/pre-validation studies) and, as a result, they get optimized. Afterwards, and prior to product launch, the Phonak Hearing Systems undergo a final quality control in terms of clinical trials. This is a pre-validation study, investigating optimized algorithms, features, functions and wearing comfort. This will be a clinical evaluation which will be conducted mono centric at Sonova AG Headquarters based in Stäfa (Switzerland).

Completed13 enrollment criteria

Early Experience of a New Implant System for Bone Conduction Hearing in the Pediatric Population...

Unilateral Mixed Conductive and Sensorineural Hearing Loss (Diagnosis)Sensorineural Hearing Loss1 more

To study the initial experience with implanting and fitting a new Bone Conduction system in pediatric patient population with conductive, mixed or single-sided deafness.

Completed10 enrollment criteria

Post Approval Study to Assure the ContInued saFety and effectIveness of Neuro Cochlear Implant System...

Sensorineural Hearing LossBilateral4 more

On June 23, 2021, the Oticon Medical Neuro Cochlear Implant System (NCIS) was granted premarket approval (PMA) in the US to treat individuals 18 years or older, with bilateral severe-to-profound sensorineural hearing loss, who obtain limited benefit from appropriately fitted hearing aid(s). To help assure the continued safety and effectiveness of an approved device, a post-approval study was required as a condition of approval under 21 CFR 814.82(a)(2). The purpose of this study is to provide longer-term data on the safety and effectiveness of the Neuro Cochlear Implant System under general conditions of use in the postmarket environment.

Not yet recruiting12 enrollment criteria

FX-322 in Adults With Severe Sensorineural Hearing Loss

Hearing LossSensorineural2 more

This is a Phase 1b, prospective, randomized, double-blind, placebo-controlled, single-dose, multicenter, safety study of FX-322, administered by intratympanic injection, in adults with severe sensorineural hearing loss.

Completed20 enrollment criteria
1...91011...27

Need Help? Contact our team!


We'll reach out to this number within 24 hrs